Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care : A Trial-based Economic Evaluation
| dc.contributor.author | Wijnen, Ben F. M. | |
| dc.contributor.author | Oberjé, Edwin J. M. | |
| dc.contributor.author | Evers, Silvia M. A. A. | |
| dc.contributor.author | Prins, Jan M. | |
| dc.contributor.author | Nobel, Hans-Erik | |
| dc.contributor.author | van Nieuwkoop, Cees | |
| dc.contributor.author | Veenstra, Jan | |
| dc.contributor.author | Pijnappel, Frank J. | |
| dc.contributor.author | Kroon, Frank P. | |
| dc.contributor.author | van Zonneveld, Laura | |
| dc.contributor.author | Van Hulzen, Astrid G. W. | |
| dc.contributor.author | van Broekhuizen, Marjolein | |
| dc.contributor.author | de Bruin, Marijn | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en | 
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en | 
| dc.date.accessioned | 2019-09-13T23:02:39Z | |
| dc.date.available | 2019-09-13T23:02:39Z | |
| dc.date.issued | 2019-02-15 | |
| dc.description | This study was funded by ZonMw (the Netherlands), program Doelmatigheidsonderzoek (grant number 171002208). This funding source had no role in study design, data collection, analysis, interpretation, or writing of the report. All authors declare that they have no competing interests. We thank the HIV-nurses and physicians from the seven HIV-clinics who were involved in the AIMSstudy (Academic Medical Center, Amsterdam; Slotervaart Hospital, Amsterdam; St. Lucas-Andreas Hospital, Amsterdam; the Leiden University Medical Center, Leiden; Haga Teaching Hospital, Den Haag; Erasmus Medical Center, Rotterdam; Isala Clinics, Zwolle) for their input and collaboration. We also would like to express our gratitude to the study participants. Written informed consent was obtained from each patient. The study has been approved by the ethics committee of each participating center. | en | 
| dc.description.status | Peer reviewed | en | 
| dc.format.extent | 10 | |
| dc.format.extent | 1103717 | |
| dc.identifier | 125725714 | |
| dc.identifier | 42dbebdd-caea-48c0-9215-fc25f1613c1c | |
| dc.identifier | 30239629 | |
| dc.identifier | 85060990822 | |
| dc.identifier | 000459668400017 | |
| dc.identifier.citation | Wijnen, B F M, Oberjé, E J M, Evers, S M A A, Prins, J M, Nobel, H-E, van Nieuwkoop, C, Veenstra, J, Pijnappel, F J, Kroon, F P, van Zonneveld, L, Van Hulzen, A G W, van Broekhuizen, M & de Bruin, M 2019, 'Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care : A Trial-based Economic Evaluation ', Clinical Infectious Diseases, vol. 68, no. 4, pp. 658-667. https://doi.org/10.1093/cid/ciy553 | en | 
| dc.identifier.doi | 10.1093/cid/ciy553 | |
| dc.identifier.iss | 4 | en | 
| dc.identifier.issn | 1058-4838 | |
| dc.identifier.other | Mendeley: 6384984d-70c3-3e64-8f1e-16bf50dd982b | |
| dc.identifier.uri | http://hdl.handle.net/2164/12936 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85060990822&partnerID=8YFLogxK | en | 
| dc.identifier.url | http://www.mendeley.com/research/costeffectiveness-costutility-adherence-improving-selfmanagement-strategy-human-immunodeficiency-vir-1 | en | 
| dc.identifier.vol | 68 | en | 
| dc.language.iso | eng | |
| dc.relation.ispartof | Clinical Infectious Diseases | en | 
| dc.subject | SDG 3 - Good Health and Well-being | en | 
| dc.subject | adherence | en | 
| dc.subject | intervention | en | 
| dc.subject | HIV/AIDS | en | 
| dc.subject | cost effectiveness | en | 
| dc.subject | cost-utility | en | 
| dc.subject | Adherence | en | 
| dc.subject | Intervention | en | 
| dc.subject | Cost-effectiveness | en | 
| dc.subject | Cost-utility | en | 
| dc.subject | VIRAL LOAD | en | 
| dc.subject | cost-effectiveness | en | 
| dc.subject | MULTICENTER | en | 
| dc.subject | FORM HEALTH SURVEY | en | 
| dc.subject | TREATMENT OUTCOMES | en | 
| dc.subject | HIV-INFECTED PATIENTS | en | 
| dc.subject | INTERVENTIONS | en | 
| dc.subject | ACTIVE ANTIRETROVIRAL THERAPY | en | 
| dc.subject | NONADHERENCE | en | 
| dc.subject | QUESTIONNAIRE | en | 
| dc.subject | MEDICATION ADHERENCE | en | 
| dc.subject | R Medicine (General) | en | 
| dc.subject | Microbiology (medical) | en | 
| dc.subject | Infectious Diseases | en | 
| dc.subject | Supplementary Data | en | 
| dc.subject.lcc | R1 | en | 
| dc.title | Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care : A Trial-based Economic Evaluation | en | 
| dc.type | Journal article | en | 
